登录 注册 会员服务 联系我们

Occurrence, Management, and Risk Factors for Adverse Drug Reactions in Multidrug Resistant Tuberculosis Patients

  • Published:2018-09 Issue:5 Volume:25 Page:e533-e540
  • ISSN:1075-2765
  • Container-title:American Journal of Therapeutics
  • language:en
  • Short-container-title:

Author:

Ahmad Nafees,Javaid Arshad,Syed Sulaiman Syed Azhar,Afridi Afsar Khan,Zainab ,Khan Amer Hayat

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology,General Medicine

Reference14 articles.

1. Predictors of two months culture conversion in multidrug-resistant tuberculosis: findings from a retrospective cohort study;Basit;PLoS One,2014

2. Doing no harm? ADRs in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria;Avong;PLoS One,2015

3. Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance;Ahmad;Int J Tuberc Lung Dis.,2015

4. Side effects associated with the treatment of multidrug-resistant tuberculosis;Törün;Int J Tuberc Lung Dis.,2005

5. Adverse related to multidrug-resistant tuberculosis treatment, Latvia, 2000–2004;Bloss;Int J Tuberc Lung Dis.,2010
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3